| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.37 | 0.06 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.07 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |